Funding to accelerate development and commercialization of company’s breakthrough blepharoplasty surgery deviceJohn Garland has been appointed as Chief Commercial OfficerBEND, Ore., July 23, 2024–(BUSINESS WIRE)–Oseru, a…
Oseru has completed a $4.7 million funding round to accelerate the development and commercialization of its Ziplyft blepharoplasty surgery device.Individuals and family offices provided financial support,…
